Stocks
Amylyx Pharmaceuticals (AMLX) Net margin US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| Net margin, % | ? | -1 039% | -6 898% | -30 835% | -892.4% | 12.9% | -130.7% | |
| Changes by years, y/y, % | -5 859pp | -23 937pp | +29 942pp | +905pp | ||||
Amylyx Pharmaceuticals. Net margin, %
Amylyx Pharmaceuticals. Net margin, changes, pp
Amylyx Pharmaceuticals (AMLX) Net margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Net margin, % | ? | 20.3% | 4.36% | -134.0% | -7 107% | -17 477% | -130.7% | |
| Changes by years, y/y, % | +15 602pp | +199pp | -136pp | -7 129pp | -17 497pp | |||
| Changes by quarters, q/q, % | -2pp | -16pp | -138pp | -6 973pp | -10 370pp | |||
